Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Healthc Manage Forum ; 29(4): 141-5, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27269815

ABSTRACT

Innovation in patient engagement and empowerment has been identified as a priority area in the Canadian healthcare system. This article describes the development and implementation of the We Should Talk campaign at an academic pediatric hospital. Through the use of a guiding theoretical framework and a multidisciplinary project team, a multimedia campaign was designed to inspire staff, patients and families to effectively communicate to improve patient safety. The We Should Talk campaign provides a case study for how an organization can foster frontline improvement through the engagement of patient, families, and healthcare providers.


Subject(s)
Communication , Health Personnel/organization & administration , Health Personnel/psychology , Patient Safety , Canada , Humans , Learning , Patient Participation
2.
Stud Health Technol Inform ; 205: 1178-82, 2014.
Article in English | MEDLINE | ID: mdl-25160375

ABSTRACT

The medical review of adverse event reports for medical products requires the processing of "big data" stored in spontaneous reporting systems, such as the US Vaccine Adverse Event Reporting System (VAERS). VAERS data are not well suited to traditional statistical analyses so we developed the FDA Adverse Event Network Analyzer (AENA) and three novel network analysis approaches to extract information from these data. Our new approaches include a weighting scheme based on co-occurring triplets in reports, a visualization layout inspired by the islands algorithm, and a network growth methodology for the detection of outliers. We explored and verified these approaches by analysing the historical signal of Intussusception (IS) after the administration of RotaShield vaccine (RV) in 1999. We believe that our study supports the use of AENA for pattern recognition in medical product safety and other clinical data.


Subject(s)
Adverse Drug Reaction Reporting Systems/organization & administration , Algorithms , Electronic Health Records/organization & administration , Intussusception/epidemiology , Pattern Recognition, Automated/methods , Rotavirus Vaccines/therapeutic use , Sentinel Surveillance , Artificial Intelligence , Humans , Incidence , Reproducibility of Results , Risk Assessment/methods , Sensitivity and Specificity , United States/epidemiology , United States Food and Drug Administration
SELECTION OF CITATIONS
SEARCH DETAIL
...